Evidence map›Paper›PMID 23738023›Full record

ReviewPLoS neglected tropical diseases2013

Potential non-invasive urine-based antigen (protein) detection assay to diagnose active visceral leishmaniasis.

Claudia Abeijon, Antonio Campos-Neto

Open access · goldAbstract readEvaluation StudyReview
In one paragraph

Review in PLoS neglected tropical diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Proteomic Analysis of Urine from Patients withTropical medicine and infectious disease · 2022
    Article
  5. Article
  6. Evaluation of Loopamp™Frontiers in cellular and infection microbiology · 2021
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Development of a Multiplexed Assay for Detection ofJournal of clinical microbiology · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Claudia AbeijonDetectoGen Inc., Grafton, Massachusetts, USA.
Antonio Campos-Neto

Funding

Novel non-invasive antigen detection assay for the diagnosis of active visceral leishmaniasis and to monitor the therapy efficacy of this diseaseR44AI113992 · NIAID · DETECTOGEN, INC. · PI ABEIJON, CLAUDIA · 2017 to 2019
$1.9M
Antigen Detection Assay for the Diagnosis of Visceral LeismaniasisR43AI084259 · NIAID · DETECTOGEN, INC. · PI ABEIJON, CLAUDIA · 2009 to 2010
$481k
NIAID NIH HHS R43 AI084259NIAID NIH HHS R43AI084259-01NIAID NIH HHS R44 AI113992
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antigens, ProtozoanClinical Laboratory TechniquesEnzyme-Linked Immunosorbent AssayHumansLeishmaniasis, VisceralParasitologySensitivity and SpecificityAntigens, Protozoan

Identifiers

PMID23738023
PMCPMC3667753
OpenAlexW1973388584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.